Skip to content

An RCT to Compare Early Continence Recovery After RARP With or Without Sustainable Functional Urethral Reconstruction

Impact of Sustainable Functional Urethral Reconstruction on Early Continence Recovery After Robotic-assisted Radical Prostatectomy: a Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04037800
Enrollment
96
Registered
2019-07-30
Start date
2019-12-08
Completion date
2021-09-28
Last updated
2022-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate Cancer, Urinary Incontinence

Keywords

Prostate cancer, Prostatectomy, Robotic surgery, Urinary incontinence, Sustainable functional urethral reconstruction

Brief summary

The study is a prospective randomized controlled trail to compare early urinary continence recovery after robotic-assisted radical prostatectomy with or without sustainable functional urethral reconstruction (SFUR).

Detailed description

Early urinary incontinence has always been a tricky problem for both patients and urologists, even though over 90% patients can recover 1 year after surgery. Many urologists are trying to modify the surgical technique to resolve this problem. Sustainable functional urethral reconstruction (SFUR) is a novel technique which may improve early urinary continence recovery for both local and locally advanced prostate cancer, and even for those with high volume prostate by providing adequate urethral length with bladder neck tubularization and making sustainable periurethral support with peritoneal flap. The purpose of this study is to verify the impact of this new technique on early recovery of urinary continence, as well as on urinary function and oncological outcomes.

Interventions

PROCEDURESFUR-RARP

Robotic-assisted radical prostatectomy with sustainable functional urethral reconstruction (SFUR)

PROCEDUREStandard RARP

Robotic-assisted radical prostatectomy with conventional RARP procedures.

Sponsors

Changhai Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
MALE
Age
40 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* ≥40, but ≤75 years old; * Histological confirmed prostate cancer; * Localized or locally advanced prostate cancer; * Presence of urinary continence prior to the procedure; * Informed consent signed;

Exclusion criteria

* Metastatic prostate cancer confirmed by ECT, PSMA or whole-body MRI; * Presence of any prostatic surgery(such as transurethral resection, laser therapy, microwave therapy, radiofrequency ablation and so on) prior to the procedure; * Radiation therapy of the prostate or pelvis prior to the procedure; * Uncontrolled intercurrent illness that would limit compliance with study requirements; * Any condition that contraindicates a radical prostatectomy;

Design outcomes

Primary

MeasureTime frameDescription
1-month urinary continence recovery rates1 month after catheter removalContinence defined as daily usage of 0-1 pad with 24-hour pad weights≤50g.

Secondary

MeasureTime frameDescription
Short-term urinary continence recoveryWithin 3 month after catheter removalTwo definitions of urinary continence: daily usage of 0-1 pad with 24-hour pad weights gain≤50g, 0 pads per day. Besides, quantification of urine leakage with 24-hour pad weight.
Peri and postoperative complications1-year follow upClavien-Dindo classification.
Post-operative oncological outcomes1-year follow upTwo assessment methods: positive surgical margin (PSM) rates and 1-year biochemical recurrence-free survival (BFS, defined as two consecutive PSA levels\>0.2 ng/mL).
Short-term urinary function and urinary function-related quality of life1-week, 2-week, 1-month, 3-month after catheter removal.International Prostatic Symptom Score(IPSS) and the IPSS quality of life score.

Other

MeasureTime frameDescription
1-year urinary function and urinary function-related quality of life1-year from the interventionInternational Prostatic Symptom Score(IPSS) and the IPSS quality of life score.
Evaluation of urinary continence with ICIQ-UI-SF1-week, 2-week, 1-month, 3-month after catheter removalInternational Consultation on Incontinence Questionnaire-Urinary Incontinence-Short Form (ICIQ-UI-SF).
Post-operative sexual function1-year from the interventionSexual Health Inventory for Men (SHIM) score \>=17.
1-year urinary continence recovery1-year from the interventionTwo definitions of urinary continence: daily usage of 0-1 pad with 24-hour pad weights gain≤50g, 0 pads per day.

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026